Delivery Order SPE2DB20D3103-SPE2DB25FN5N4
Award Date 4/23/25
Potential Completion Date 5/14/25
Potential Value $4.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,168.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testopel 75 mg pellets (10-count units) on October 20, 2025, with an ultimate completion date of November 10, 2025. This non-competitive, non-set-aside delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $4,115.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testopel 75 mg pellets (100-count units) on May 2, 2025, with an ultimate completion date of May 23, 2025. This non-competitive delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child contract under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Testopel 75 mg pellets (100-count units) valued at $7,968.84 with a firm fixed price structure and no set-aside designation. The contract, issued on November 5, 2025, will be completed by November 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,057.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testopel 75 mg pellets (10 count) on October 16, 2025, with completion targeted for November 6, 2025. This non-set-aside award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Testopel 75 mg pellets (100-count units) with a ceiling value of $3,984.42. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by November 19, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as both the place of performance and the awardee's headquarters, positioning the company to fulfill...
- The Defense Logistics Agency awarded a delivery order valued at $8,231.20 to AmerisourceBergen Drug Corp for the supply of Testopel 75 mg pellets (10 units) on September 17, 2025. This competitive, firm fixed-price delivery order is scheduled for completion by October 8, 2025, with fulfillment based at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,057.80 to AmerisourceBergen Drug Corp for Testopel 75 mg pellets on June 11, 2025, with a completion date of July 3, 2025. This firm fixed price delivery order represents a non-competitive set-aside transaction and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Testopel is a testosterone replacement therapy product used in hormone treatment applications within military and federal healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Testopel 75 mg pellets (100-count units) with a ceiling value of $8.2K. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures and scheduled for completion by September 5, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for the supply of Testopel 75 mg pellets (10 count) under a firm fixed price contract. The delivery order, valued at $4,115.60, is scheduled for completion by November 26, 2025, and was competitively awarded without any set-aside designation. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $4,000 to Amerisourcebergen Drug Corporation for the supply of 100 units of Testopel 75 mg pellets. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of three weeks concluding in early September. As a major supplier of pharmaceuticals to the Department of Defense, this order for testosterone replacement therapy supports DLA's provision of medical...